Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
2(22%)
Results Posted
0%(0 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_1
1
11%
Ph phase_2
8
89%

Phase Distribution

1

Early Stage

8

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
8(88.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Recruiting2
Enrolling by invitation2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
60.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (11.1%)
Phase 28 (88.9%)

Trials by Status

recruiting222%
completed333%
enrolling_by_invitation222%
terminated222%

Recent Activity

2 active trials
Showing 5 of 9
enrolling_by_invitationphase_2

Long-term Safety and Tolerability of BHV-7000

NCT06443463
recruitingphase_2

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

NCT06132893
recruitingphase_2

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

NCT06309966
enrolling_by_invitationphase_1

A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia

NCT07262268
completedphase_2

Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

NCT06423781
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06443463Phase 2

Long-term Safety and Tolerability of BHV-7000

Enrolling By Invitation
NCT06132893Phase 2

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
NCT06309966Phase 2

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
NCT07262268Phase 1

A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia

Enrolling By Invitation
NCT06423781Phase 2

Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

Completed
NCT06425159Phase 2

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

Terminated
NCT06419608Phase 2

Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

Completed
NCT06423794Phase 2

BHV-7000 Open-Label Extension Bipolar Mania Study

Terminated
NCT06419582Phase 2

BHV-7000 Acute Treatment of Bipolar Mania

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9